NFKB1 and COVID-19: A possible mechanism that reinforces its possible role in COVID-19 treatment is reported by a recent study that showed that the upregulation of miR-574–5p inhibits TLR4/ NF-kB signaling and downregulates the production of proinflammatory cytokines in patients with acute respiratory distress syndrome [46].